Cumberland Partners LTD Medtronic PLC Transaction History

Cumberland Partners LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$99.53 - $127.75 $9.68 Million - $12.4 Million	-97,281 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$122.75 - $135.17 $1.48 Million - $1.63 Million	12,040 Added 14.12%	97,281 $12.2 Million
Q2 2021 Aug 09, 2021	SELL	$118.19 - $131.5 $299,257 - $332,958	-2,532 Reduced 2.88%	85,241 $10.6 Million
Q1 2021 May 11, 2021	SELL	$111.18 - $119.74 $326,202 - $351,317	-2,934 Reduced 3.23%	87,773 $10.4 Million
Q4 2020 Feb 11, 2021	SELL	$100.57 - $117.14 $98,256 - $114,445	-977 Reduced 1.07%	90,707 $10.6 Million
Q3 2020 Nov 03, 2020	SELL	$90.13 - $108.78 $493,371 - $595,461	-5,474 Reduced 5.63%	91,684 $9.53 Million
Q2 2020 Aug 04, 2020	SELL	$84.11 - $103.33 $4.38 Million - $5.38 Million	-52,087 Reduced 34.9%	97,158 $8.91 Million
Q1 2020 May 13, 2020	SELL	$72.92 - $121.3 $443,936 - $738,474	-6,088 Reduced 3.92%	149,245 $13.5 Million
Q4 2019 Feb 07, 2020	SELL	$104.49 - $114.54 $606,042 - $664,332	-5,800 Reduced 3.6%	155,333 $17.6 Million
Q3 2019 Nov 13, 2019	SELL	$98.02 - $111.18 $3.28 Million - $3.72 Million	-33,455 Reduced 17.19%	161,133 $17.5 Million
Q2 2019 Aug 08, 2019	BUY	$84.15 - $99.38 $6.82 Million - $8.05 Million	81,015 Added 71.33%	194,588 $19 Million
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $6.12 Million - $6.97 Million	74,285 Added 189.08%	113,573 $10.3 Million
Q4 2018 Feb 13, 2019	BUY	$85.8 - $99.49 $214,500 - $248,725	2,500 Added 6.8%	39,288 $3.57 Million
Q2 2018 Aug 09, 2018	BUY	$77.48 - $87.83 $2.85 Million - $3.23 Million	36,788 New	36,788 $3.15 Million

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $116B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.